Literature DB >> 16399053

Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies.

Tamara T Koopmann1, Marielle Alders, Roselie J Jongbloed, Silvia Guerrero, Marcel M A M Mannens, Arthur A M Wilde, Connie R Bezzina.   

Abstract

BACKGROUND: The numerous mutations in the long QT syndrome (LQTS)-associated genes reported to date are point mutations or small insertions and deletions in coding regions or at splice junctions.
OBJECTIVES: The purpose of this study was to determine the relative copy number of gene exons in a series of mutation-negative LQTS probands.
METHODS: We used a quantitative multiplex approach because the polymerase chain reaction (PCR)-based exon-scanning methodologies routinely utilized in mutation analysis are unable to detect large genomic alterations.
RESULTS: We identified the first large gene rearrangement consisting of a tandem duplication of 3.7 kb in KCNH2 responsible for LQTS in a Dutch family. This large duplication is expected to lead to nonfunctional or severely debilitated channels, thereby decreasing I(Kr).
CONCLUSION: Our findings have implications for genetic testing in the approximately 30% of LQTS patients in whom conventional mutation screening fails to uncover a mutation. Analysis for large gene alterations such as the one described herein in routine genetic testing may provide a genetic diagnosis in a number of these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16399053     DOI: 10.1016/j.hrthm.2005.10.014

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  20 in total

1.  Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing.

Authors:  David J Tester; Amber J Benton; Laura Train; Barbara Deal; Linnea M Baudhuin; Michael J Ackerman
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

2.  Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.

Authors:  Tomas Robyns; Cuno Kuiperi; Jeroen Breckpot; Koenraad Devriendt; Erika Souche; Johan Van Cleemput; Rik Willems; Dieter Nuyens; Gert Matthijs; Anniek Corveleyn
Journal:  Eur J Hum Genet       Date:  2017-10-10       Impact factor: 4.246

Review 3.  Use of contemporary genetics in cardiovascular diagnosis.

Authors:  Alfred L George
Journal:  Circulation       Date:  2014-11-25       Impact factor: 29.690

Review 4.  KCNH2 pharmacogenomics summary.

Authors:  Connie Oshiro; Caroline F Thorn; Dan M Roden; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-12       Impact factor: 2.089

Review 5.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

Review 6.  Genetics of long QT syndrome.

Authors:  David J Tester; Michael J Ackerman
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

7.  Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Authors:  Jamie D Kapplinger; David J Tester; Benjamin A Salisbury; Janet L Carr; Carole Harris-Kerr; Guido D Pollevick; Arthur A M Wilde; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-06-23       Impact factor: 6.343

Review 8.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

Review 9.  Inherited cardiac arrhythmias.

Authors:  Peter J Schwartz; Michael J Ackerman; Charles Antzelevitch; Connie R Bezzina; Martin Borggrefe; Bettina F Cuneo; Arthur A M Wilde
Journal:  Nat Rev Dis Primers       Date:  2020-07-16       Impact factor: 52.329

10.  The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome.

Authors:  Sally-Ann B Clur; Priya Chockalingam; Luc H Filippini; Ari P Widyanti; Marc Van Cruijsen; Nico A Blom; Mariel Alders; Nynke Hofman; Arthur A M Wilde
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.